Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection

Michael T. Brady, Carrie L. Byington, Herbert Dele Davies, Kathryn M. Edwards, Mary Anne Jackson, Yvonne A. Maldonado, Dennis L. Murray, Walter A. Orenstein, Mobeen H. Rathore, Mark H. Sawyer, Gordon E. Schutze, Rodney E. Willoughby, Theoklis E. Zaoutis, Henry H. Bernstein, David W. Kimberlin, Sarah S. Long, H. Cody Meissner, Marc A. Fischer, Bruce G. Gellin, Richard L. GormanLucia H. Lee, R. Douglas Pratt, Jennifer S. Read, Joan L. Robinson, Marco Aurelio Palazzi Safadi, Jane F. Seward, Jeffrey R. Starke, Geoffrey R. Simon, Tina Q. Tan, Joseph A. Bocchini, W. Robert Morrow, Larry K. Pickering, Geoffrey L. Rosenthal, Dan L. Stewart, Jennifer M. Frantz, Shawn L. Ralston, Allan S. Lieberthal, Brian K. Alverson, Jill E. Baley, Anne M. Gadomski, David W. Johnson, Michael J. Light, Nizar F. Maraqa, Eneida A. Mendonca, Kieran J. Phelan, Joseph J. Zorc, Danette Stanko-Lopp, Sinsi Hernández-Cancio, Mark A. Brown, Ian Nathanson, Elizabeth Rosenblum, Stephen Sayles, Caryn Davidson

Research output: Contribution to journalArticlepeer-review

311 Scopus citations

Fingerprint Dive into the research topics of 'Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection'. Together they form a unique fingerprint.

Medicine & Life Sciences